Plain-English translation of NCT07016360 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing two different ways to treat plantar warts—the thick, stubborn growths that appear on the bottom of your feet and tend to come back. Researchers want to see whether adapalene gel, a topical medication, works as well as or better than liquid nitrogen (a freezing treatment) that doctors have used for years. You would receive one of these two treatments and be monitored to see which one is more effective.
Plantar warts are caused by a virus and can be frustrating because they often return even after treatment. Doctors want to find out if this medication offers a good alternative to freezing, which might be more convenient or work better for some patients.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either adapalene gel applied to your warts or liquid nitrogen freezing treatment. The study will follow you over time to measure how well each treatment works at eliminating your warts and preventing them from returning. You'll likely have several visits to the clinic so the research team can check your progress and document the results.
AI-generated summary from trial data · Sep 11, 2026 · Not medical advice
Pakistan
Post-approval monitoring
Sponsor
Khyber Teaching Hospital
Enrollment target
~98 participants
Started
September 2025
Primary completion
February 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 60 Years
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Saba Naz, MBBS
Khyber Teaching Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.